About EOCI

EOCI has a demonstrated track record of over 13 years in the CME industry. Our reputation is a result of business integrity and professional agility, as well as resourcefulness and creativity.

In addition to the 25 to 30 CME programs we develop annually, EOCI produces other high-calibre specialist-focused annual congresses in Mont-Tremblant, and Montreal:

Arrhythmia Update Plus 2019

February 6 to February 9, 2019

2019 Archived Presentations

Thursday, February 7th, 2019
7:15 a.m. Keynote
AF: The First 100 Years
Robert Hart, MD
7:45 a.m. COMPASS – New Analyses John Eikelboom, MBBS, MSc
8:15 a.m. Arrhythmias and HF Jeff Healey, MD, MSc
8:45 a.m. New Trials in Stroke Prevention Robert Hart, MD
9:30 a.m. Debate: Cardioversion of AF Causes Stroke Which Would be Prevented by Anticoagulation L. Brent Mitchell, MD
Jeff Healey, MD, MSc
  Meet the Expert
1:30 p.m. Hands-On Echo Challenge Hisham Dokainish, MD
2:15 p.m. Optimization of Care at Time of HF Discharge Sean Virani, MD, MSc
3:00 p.m. Managing the Complicated HF Patient with an Atrial Arrhythmia – Ablation or Drugs? Jeff Healey, MD, MSc
3:45 p.m. Stroke Cases Relevant to Cardiologists Robert Hart, MD
Friday, February 8th, 2019
7:15 a.m. New Trials in HF Sean Virani, MD, MSc
7:45 a.m. Case Studies: AF and HF Paul Dorian, MD, MSc
8:30 a.m. Improving Delivery of Care to the HF Patient Sean Virani, MD, MSc
9:00 a.m. Up-to-date Management of Diabetes: Perspectives from AHA 2018 Late Breaking Trials G.B. John Mancini, MD
9:30 a.m. Does AF Ablation Prevent Stroke and Death? L. Brent Mitchell, MD
2:30 p.m. Diabetes in the CV Patient: Q&A with an Endo David Shu, MD
3:30 p.m. High-Risk and Vulnerable AF Patients Paul Dorian, MD, MSc
4:30 p.m. Difficult Syncope Cases in Everyday Practice Carlos A. Morillo, MD
Saturday, February 9th, 2019
7:15 a.m. Case Studies: AF and CAD Paul Dorian, MD, MSc
7:45 a.m. New Paradigms in CAD Prevention: A Focus on Residual Risk Due to Lipids and Inflammation? G.B. John Mancini, MD
8:15 a.m. My Patient Bleeds on a NOAC - Reversal, Re-starting Anticoagulation, Prognosis Deborah Siegal, MD
9:30 a.m. Update on Syncope Management Carlos A. Morillo, MD
Thursday, February 1st, 2018
7:05 a.m. Case Studies in Silent AF Paul Dorian, MD, MSc
7:35 a.m. Case Studies – Left Atrial Appendage Occlusion: Devices/Surgery Jeff Healey, MD, MSc
8:05 a.m. Prevention of Cardiovascular Events in Peripheral Artery Disease – Role of Anticoagulation Sonia Anand, MD, PhD
9:00 a.m. Cardioprotection in Chronic Atherosclerosis: Is COMPASS a New Paradigm? John Eikelboom, MBBS, MSc
9:30 a.m. Antithrombotic Therapy in AF: 3 Decades of Progress – Where to Next? Stuart Connolly, MD
Friday, February 2nd, 2018
7:00 a.m. Role of SGLT2 Inhibitors and GLP-1 Receptors in Cardioprotection David Fitchett, MD
7:35 a.m. Mechanism of Cardioprotection in Diabetes G.B. John Mancini, MD
  Hotline sessions
  8:30 a.m. — BRUISE 2 David Birnie, MD
  9:00 a.m. — CASTLE and Other Upcoming AF Outcome Trials Jeff Healey, MD, MSc
  9:30 a.m. — Recent Trials of NOACs in Cancer Gary Raskob, PhD
Saturday, February 3rd, 2018
7:00 a.m. Modulating Inflammation to Prevent ASCVD: the CANTOS and CIRT trials Jacques Genest, MD
7:30 a.m. ECG Quiz George Klein, MD
9:00 a.m. PCSK9 to Reduce Cardiovascular Events: Effective? Cost Effective? Jean Grégoire, MD
9:30 a.m. Innovation in Cardiac Rhythm Devices: S-ICD, MRI-Compatible, Remote Monitoring, and More L. Brent Mitchell, MD

Please Note: The User name is "AU2017"

Thursday, February 2, 2017
7:05 a.m. What’s New in AF Diagnosis and Treatment? Stuart J. Connolly, MD
7:25 a.m. Case Studies in Stroke Prevention with NOACs and Warfarin (Including Valvular Heart Disease) Paul Dorian, MD, MSc
7:55 a.m. Importance of Controlling Bleeding in Use of Antithrombotic Therapy — What are the Data? Reversal of Anticoagulation — Idarucizumab, Andexanet and PCC — What are the Results of these Studies? John Eikelboom, MD, MSc
9:00 a.m. ECG Analysis and Quiz — Wide Complex Tachycardia Adrian Baranchuk, MD
9:30 a.m. Controversies in Prevention — Salt Guidelines, Lipids and Hypertension Lessons from HOPE 3, SPRINT Jacques Genest, MD
Friday, February 3, 2017
— Managing Sudden Unexplained Death and Cardiac Arrest in the Young
— Lessons from the First 1000 patients in the CASPER Registry
Andrew Krahn, MD
7:35 a.m. Case Studies in Pacemaker/ICD Therapy — When to (Not) Implant, Device Detected AF, … L. Brent Mitchell, MD
8:10 a.m. An Intelligent Approach to the Patient Referred for Syncope Carlos Morillo, MD
  Hotline sessions
  9:00 a.m. — The ALPS Study — Amio Lido and Placebo in Cardiac Arrest Paul Dorian, MD, MSc
  9:20 a.m. — VT Ablation — VANISH Study John Sapp, MD
  9:40 a.m. — PIONEER — Double/Triple Antithrombotic Therapy in ACS John Eikelboom, MD, MSc
5:00 p.m. Workshop sessions
  1. Case studies in CHF Anique Ducharme, MD, MSc
  2. ECG Cases Adrian Baranchuk, MD
  3. Arrhythmia in Pregnancy Eaine Gordon, MD
  4. Long QT, Brugada and Other Inherited Arrhythmias Seen as Out-Patients Andrew Krahn, MD
Saturday, February 4, 2017
7:00 a.m. Can we Deliver Care Better in Canada? And How? Sacha Bhatia, MD
7:30 a.m. New Options for CHF Sacubitril — Sartan (Entresto), Ivabradine, Strength Training, Self Help Apps Anique Ducharme, MD, MSc
8:00 a.m. A 72 Year Old Male with Persistent Systematic AF  
  The Case Paul Dorian, MD, MSc
  The Argument for Recommending Ablation Carlos Morillo, MD
  The Argument for Recommending Amiodarone Stuart J. Connolly, MD
9:00 a.m. Mass Screening to Detect AF — Effective, Cost-Effective? Jeff Healey, MD, MSc
9:30 a.m. What’s New in the Cath Lab — Mitral Clip, Other Devices, Total Artery Occlusion Chris Buller, MD

Please Note: The User name is "AU2016"

Thursday, January 28, 2016
7:05 a.m. What have we learned about NOACs from the real world studies? Stuart J. Connolly, MD
7:40 a.m. Case studies in stroke prevention with NOACs and warfarin Paul Dorian, MD, MSc
8:15 a.m. Managing acute bleeding on oral anticoagulation in the era of the new NOAC antidotes Deborah Siegal, MD, MSc
9:20 a.m. Managing patients with both CAD and AF: Risks and benefits of dual antiplatelet and triple therapy Jean-François Tanguay, MD
9:55 a.m. Exercise and the heart: How much is good, how much is too much? Paul Dorian, MD, MSc
Friday, January 29, 2016
7:00 a.m. Innovations in surgical management of valvular heart disease - KEYNOTE PRESENTATION Tirone E. David, MD
7:35 a.m. Improving our understanding of the large RCTs of NOACS in AF Stuart J. Connolly, MD
8:10 a.m. Differential diagnosis of narrow complex tachycardias Adrian Baranchuk, MD
9:15 a.m. ECG Update Adrian Baranchuk, MD
9:30 a.m. Leadless pacemaker L. Brent Mitchell, MD
9:50 a.m. Results of CHAMPION - Pressure monitoring in CHF Anique Ducharme, MD, MSc
10:10 a.m. New insights from MADIT-CRT, MIRACLE and REVERSE Michel White, MD
4:00 p.m. Workshop sessions
  Case studies | When heart failure and arrhythmias meet: Who is guilty? Should we treat both? Anique Ducharme, MD, MSc
Michel White, MD
  Ventricular arrhythmia (frequent PVCs, ventricular tachycardia, ablation) L. Brent Mitchell, MD
John L. Sapp, MD
  Case studies in syncope (when to worry, what tests to order) Adrian Baranchuk, MD
George J. Klein, MD
  Atrial fibrillation management Paul Dorian, MD, MSc
Jean-François Tanguay, MD
Saturday, January 30, 2016
7:00 a.m. Update in management of acute/severe heart failure (including mechanical support modalities) Michel White, MD
7:35 a.m. Case studies of patients with tachycardia and bradycardia in heart failure Anique Ducharme, MD, MSc
8:10 a.m. Update on ablation for atrial fibrillation: Risk and benefits George J. Klein, MD
9:20 a.m. Cardiac arrest in normal hearts and inherited cardiomyopathy Andrew D. Krahn, MD
9:55 a.m. Does this patient need a device? Cases in CRT and ICD John L. Sapp, MD

Subscribe to get the latest updates

Receive the latest news on the Arrhythmia Update Conference directly in your mailbox.